Typhus laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 3: Line 3:
{{CMG}} ; {{AE}} {{ADG}}
{{CMG}} ; {{AE}} {{ADG}}
==Overview==
==Overview==
Diagnosis of typhus fever is usually based on clinical recognition and serology; the latter requires comparison of acute- to convalescent-phase serology, so is only helpful in retrospect. Etiologic agents can generally only be identified to the genus level by serologic testing. PCR and immunohistochemical analyses may also be helpful.
Diagnosis of typhus fever is usually based on clinical recognition and serology; the latter requires comparison of acute- to convalescent-phase serology, so is only helpful in retrospect. Etiologic agents can generally only be identified to the genus level by serologic testing. PCR and immunohistochemical analyses may also be helpful.<ref name="pmid17205447">{{cite journal |vauthors=Blacksell SD, Bryant NJ, Paris DH, Doust JA, Sakoda Y, Day NP |title=Scrub typhus serologic testing with the indirect immunofluorescence method as a diagnostic gold standard: a lack of consensus leads to a lot of confusion |journal=Clin. Infect. Dis. |volume=44 |issue=3 |pages=391–401 |year=2007 |pmid=17205447 |doi=10.1086/510585 |url=}}</ref><ref name="pmid10853230">{{cite journal |vauthors=Kovácová E, Kazár J |title=Rickettsial diseases and their serological diagnosis |journal=Clin. Lab. |volume=46 |issue=5-6 |pages=239–45 |year=2000 |pmid=10853230 |doi= |url=}}</ref><ref name="pmid2678763">{{cite journal |vauthors=Chong Y |title=Application of serologic diagnosis of tsutsugamushi disease (scrub typhus) in Korea where the disease was recently recognized to be endemic |journal=Yonsei Med. J. |volume=30 |issue=2 |pages=111–7 |year=1989 |pmid=2678763 |doi=10.3349/ymj.1989.30.2.111 |url=}}</ref>
 
==Laboratory Findings==
==Laboratory Findings==
===Electrolyte and Biomarker Studies===
===Electrolyte and Biomarker Studies===

Revision as of 19:44, 9 May 2017

Typhus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Typhus from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Typhus laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Typhus laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Typhus laboratory findings

CDC on Typhus laboratory findings

Typhus laboratory findings in the news

Blogs on Typhus laboratory findings

Directions to Hospitals Treating Typhus

Risk calculators and risk factors for Typhus laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Diagnosis of typhus fever is usually based on clinical recognition and serology; the latter requires comparison of acute- to convalescent-phase serology, so is only helpful in retrospect. Etiologic agents can generally only be identified to the genus level by serologic testing. PCR and immunohistochemical analyses may also be helpful.[1][2][3]

Laboratory Findings

Electrolyte and Biomarker Studies

A complete blood count (CBC) may show anemia and low platelets. Other blood tests for typhus may show:

Serology testing

  • The indirect immunofluorescence assay (IFA) is generally considered the reference standard, but is usually not available in developing countries where this disease is endemic.
  • Other serological tests include ELISA and indirect immunuoperoxidase (IIP) assays. Weil-Felix OX-K agglutination assays may be used in some international settings but lack sensitivity and specificity and are not generally used in the United States.
  • These assays can detect either IgG or IgM antibodies.
  • Diagnosis is typically confirmed by documenting a four-fold rise in antibody titer between acute and convalescent samples.
  • Acute specimens are taken during the first week of illness and convalescent samples are taken 2–4 weeks later.
  • IgG antibodies are considered more accurate than IgM, but detectable levels of IgG antibody generally do not appear until 7–10 days after the onset of illness.
  • The most rapid and specific diagnostic assays for scrub typhus rely on molecular methods like polymerase chain reaction (PCR), which can detect DNA in a whole blood, eschar swab, or tissue sample
  • Rickettsia typhi can be detected via indirect immunofluorescence antibody (IFA) assay, immunohistochemistry (IHC), polymerase chain reaction (PCR) assays using blood, plasma, or tissue samples, or culture isolation. PCR is most sensitive on samples taken during the first week of illness, but prior to the start of doxycycline.

Diagnostic Criteria

A diagnosis of rickettsial diseases is based on two or more of the following:

  • clinical symptoms and an epidemiologic history compatible with a rickettsial disease,
  • the development of specific convalescent-phase antibodies reactive with a given pathogen or antigenic group,
  • a positive polymerase chain reaction test result,
  • specific immunohistologic detection of rickettsial agent,
  • isolation of a rickettsial agent. Ascertaining the likely place and the nature of potential exposures is particularly helpful for accurate diagnostic testing.

References

  1. Blacksell SD, Bryant NJ, Paris DH, Doust JA, Sakoda Y, Day NP (2007). "Scrub typhus serologic testing with the indirect immunofluorescence method as a diagnostic gold standard: a lack of consensus leads to a lot of confusion". Clin. Infect. Dis. 44 (3): 391–401. doi:10.1086/510585. PMID 17205447.
  2. Kovácová E, Kazár J (2000). "Rickettsial diseases and their serological diagnosis". Clin. Lab. 46 (5–6): 239–45. PMID 10853230.
  3. Chong Y (1989). "Application of serologic diagnosis of tsutsugamushi disease (scrub typhus) in Korea where the disease was recently recognized to be endemic". Yonsei Med. J. 30 (2): 111–7. doi:10.3349/ymj.1989.30.2.111. PMID 2678763.

Template:WH Template:WS